Drugs Online |
 |
 | ||
|
ARRENO Aggrenox |
|
| ||
Drugs Online » Prescription Drugs 2 » ARRENO Aggrenox The combination of aspirin and extended-release dipyridamole is in a class of drugs called antiplatelet agents. It works by preventing excessive blood clotting. It is used to reduce the risk of stroke in patients who have had or are at risk of stroke.The combination of aspirin and extended-release dipyridamole comes as a capsule to take by mouth. It is usually taken twice a day one capsule in the morning and one in the evening. Aspirin and extended-release dipyridamole should be swallowed whole. Do not open crush break or chew the capsules.The combination of aspirin and extended-release dipyridamole decreases the risk of having a stroke but does not eliminate that risk. Continue to take aspirin and extended-release dipyridamole even if you feel well. Do not stop taking aspirin and extended-release dipyridamole without talking to your doctor. Buy ARRENO Aggrenox and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About ARRENO Aggrenox: Product Type: Prescription Drugs 2 ARRENO ( Aggrenox Generic Aspirin/Dipyridamole ) ARRENO (Aggrenox Generic Aspirin/Dipyridamole) Aggrenox Generic Aspirin/Dipyridamole 25/200mg 3 x 60 Capsules-ER 60 Capsule-ER 2 x 60 Capsules-ER Aggrenox Generic Aspirin/Dipyridamole ARRENO
View more Prescription Drugs 2 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
